Nepafenac

奈帕芬胺

Report date: 2022/11/25 16:34:12
NME

Base Information

Drug NameNepafenac
Drug Alias Name奈帕酚胺NepafenacumnepafenacoNevanacIlevro +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsDiabetic macular oedemaPainPain, Postoperative +[8] 
Global Approved IndicationsPainPain, PostoperativeInflammation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/08/19
Country/TerritoryUnited StatesMexicoFrance +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesHarrow Health IncHarrow Eye LLCAlcon +[4] 
Inactive CompaniesJaeb Center For Health Research IncActavis IncAsociación Para Evitar La Ceguera En México +[5] 
Active IndicationsPainPain, PostoperativeInflammation
Inactive IndicationsDiabetic macular oedemaMacular EdemaDiabetic Retinopathy +[5] 

Other Information

ATC CodeS01BC10
Related LinksWikipediaDrugBankKEGG